BSECorp. ActionDividend14 Aug 2026
Natco Pharma Ltd
Board of Directors at their Meeting held on today i.e. 14th August, 2026 had declared Interim Dividend of Rs.1.50 (75%) for face value of Rs.2/- each
Natco Pharma Ltd has declared an interim dividend of Rs.1.50 (75%) per equity share of Rs.2/- each for the financial year 2026-27. The record date is fixed as Thursday, 20th August 2026, and the payment will start from 26th August 2026.
BSEBoard Meeting▲ PositiveResults14 Aug 2026
Natco Pharma Ltd
Outcome of Board Meeting
Natco Pharma Ltd announced unaudited financial results for Q1 FY27, with consolidated revenue of ₹794.4 Crore and profit after tax of ₹206.5 Crore. The company declared an interim dividend of ₹1.5 per equity share. The Board also approved the reconstitution of Risk Management Committee and Environment, Social and Governance Committee.
BSECompany UpdateResults11 Aug 2026
Natco Pharma Ltd
The Company will host an Earnings Call with Investors / Analysts on Friday, the 14th August, 2026 at 17:30 PM IST to discuss the Un-audited Financial Results of the Company for the quarter ....
Natco Pharma Ltd will host an earnings call with investors and analysts on August 14, 2026, to discuss its un-audited financial results for the quarter ended June 30, 2026.
BSEBoard MeetingFundraise11 Aug 2026
Natco Pharma Ltd
Natco Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Further to our earlier intimation ....
Natco Pharma Ltd has informed BSE that the company's Board of Directors will meet on August 14, 2026 to consider raising funds through various methods, including public issue, preferential issue, rights issue, and private placement.
BSEBoard MeetingResults6 Aug 2026
Natco Pharma Ltd
Natco Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Un-audited Financial Results for ....
Natco Pharma Ltd has scheduled a board meeting on August 14, 2026, to consider un-audited financial results for the quarter ended June 30, 2026, and to declare an interim dividend, if any.